5-LOX Inhibitor with AprèsFlex® is made with a standardized Boswellia serrata extract that promotes a healthy inflammatory response and absorbs 52% better than standard Boswellia extracts. Compounds in Boswellia extract have been shown to bind directly to 5-LOX, an enzyme that transforms fatty acids into inflammatory factors like leukotriene B4. A compound in Boswellia called AKBA is the key to this beneficial action. Each 100 mg vegetarian capsule of 5-LOX Inhibitor with AprèsFlex® is standardized to provide 20% of active AKBA from Boswellia.

Dosage and Use: To inhibit the 5-lipoxygenase enzyme, take one (1) capsule daily, or as recommended by a healthcare practitioner.